Chemistry and biology of DNA-binding small molecules

Current Science

Volumn 102, Issue 2, 2012, Pages 212-231

  Paul, Ananya ^a   Bhattacharya, Santanu ^a,b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

DNA binding molecules; Duplex DNA; G quadruplex structures; Transcription

Indexed keywords

EID: 84859795917     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (220)

1. Crick, F., Central dogma of molecular biology. Nature, 1970, 227, 561-563.
2. Latchman, D., Eukaryotic Transcription Factors, Elsevier Academic Press, London, 2004, 4th edn, p. 1.
3. Mitchell, P. J. and Tjian, R., Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science, 1989, 245, 371-378.
4. Gottesfeld, J. M., Neely, L., Trauger, J. W., Baird, E. E. and Dervan, P. B., Regulation of gene expression by small molecules. Nature, 1997, 387, 202-205.
5. Dickerson, R. E., Drew, H. R., Conner, B. N., Wing, M., Fratini, A. V. and Kopka, M. L., The anatomy of A-, B-, and Z-DNA. Science, 1982, 216, 475-485.
6. Saenger, W., Principles of Nucleic Acid Structure, Biochemical Education, Springer-Verlag, New York, 1984.
7. Bauer, G. B. and Povirk, L. F., Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence. Nucleic Acids Res., 1997, 25, 1211-1218.
8. Hurley, L. H., DNA and its associated processes as targets for cancer therapy. Nature Rev. Cancer, 2002, 2, 188-200.
9. Reedijk, J., New clues for platinum antitumour chemistry: Kinetically controlled metal binding to DNA. Proc. Natl. Acad. Sci. USA, 2003, 100, 3611-3616.
10. Clement, B. and Jung, F., N-Hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide. Drug Metab. Dispos., 1994, 22, 486-497.
11. Remers, W. A., The Chemistry of Antitumor Antibiotics, Wiley, New York, 1979, p. 1.
12. Williams, L. D., Egli, M. and Gao, Q., Structure of nogalamycin bound to a DNA hexamer. Proc. Natl. Acad. Sci. USA, 1990, 87, 2225-2229.
13. Neidle, S., DNA minor-groove recognition by small molecules. Natl. Prod. Rep., 2001, 18, 291-309.
14. Goldman, A., (eds Blackburn, G. M. and Gait, M. J.), Oxford University Press, New York, 1996, 2nd edn, vol. 2, p. 376.
15. Skibo, E. B., Xing, C. and Groy, T., Recognition and cleavage at the DNA major groove. Bioorg. Med. Chem., 2001, 9, 2445-2459.
16. Schleif, R., DNA binding by proteins. Science, 1988, 241, 1182-1187.
17. Thuong, N. T. and Hélène, C., Stereospecific detection and modification of double helix DNA by oligonucleotides. Angew. Chem., Int. Ed. Engl., 1993, 32, 666-690.
18. Jain, A. K. and Bhattacharya, S., Groove binding ligands for the interaction with parallel-stranded ps-duplex DNA and triplex DNA. Bioconjugate Chem., 2010, 21, 1389-1403
19. Giovannangeli, C. and Hélène, C., Triplex-forming molecules for modulation of DNA information processing. Curr. Opin. Mol. Ther., 2000, 2, 288-296.
20. Nielsen, P. E., Peptide nucleic acids as therapeutic agents. Curr. Opin. Struct. Biol., 1999, 9, 353-357;
21. Ganesh, K. N. and Kumar, V. A., Conformationally constrained PNA analogs: Structural evolution towards DNA/RNA binding selectivity. Acc. Chem. Res., 2005, 38, 404-412.
22. Lohse, J., Dahl, O. and Nielsen, P. E., Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc. Natl. Acad. Sci. USA, 1999, 96, 11804-11808.
23. Bailly, C. and Chaires, J. B., Sequence-specific DNA minor groove binders. Design and synthesis of netropsin and distamycin analogs. Bioconjugate Chem., 1998, 9, 513-538.
24. Dervan, P. B., Molecular recognition of DNA by small molecules. Bioorg. Med. Chem., 2001, 9, 2215-2235.
25. Lown, J. W. and Graham, B. J., DNA sequence recognition altered bis-benzimidazole minor groove binders. In Advances in DNA Sequence Specific Agents (ed. Graham, B. J.), JAI Press, Greenwich, 1997, vol. 3, p. 67-95.
26. Pullman, B. and Pullman, A., Structural factors involved in the binding of netropsin and distamycin A to nucleic acids. Stud. Biophys., 1981, 86, 95-102.
27. Hamelberg, D., Williams, L. D. and Wilson, W. D., Influence of the dynamic positions of cations on the structure of the DNA minor groove: sequence-dependent effects. J. Am. Chem. Soc., 2001, 123, 7745-7755.
28. Bailly, C., Payet, D., Travers, A. A. and Waring, M. J., PCRbased development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groovebinding drugs and proteins. Proc. Natl. Acad. Sci. USA, 1996, 93, 13623-13628.
29. Bhattacharya, S. and Thomas, M., Facile synthesis of oligopeptide distamycin analogs devoid of hydrogen-bond donors or acceptors at the N-terminus: sequence-specific duplex DNA binding as a function of peptide chain length. Tetrahedron Lett., 2000, 41, 5571-5575.
30. Eriksson, S., Kim, S. K., Kubista, M. and Norden, B., Binding of 4'6-diamino-2-phenylindole (DAPI) to AT regions of DNA: evidence for an allosteric conformational change. Biochemistry, 1993, 32, 2987-2998.
31. Brown, D. G. et al., Crystal structure of a berenil-dodecanucleotide complex: the role of water in sequence-specific ligand binding. EMBO J., 1990, 9, 1329-1334.
32. Dervan, P. B. and Bürli, R. W., Sequence-specific DNA recognition by polyamides. Curr. Opin. Chem. Biol., 1999, 3, 688-693.
33. White, S., Szewczyk, J. W., Turner, J. M., Baird, E. E. and Deran, P. B., Recognition of the four Watson-Crick base-pairs in the DNA minor groove by synthetic ligands. Nature, 1998, 391, 468-471.
34. Bhattacharya, S. and Thomas, M., DNA binding properties of novel distamycin analogs that lack the leading amide unit at the N-terminus. Biochem. Biophys. Res. Commun., 2000, 267, 139-144;
35. Bhattacharya, S. and Thomas, M., Novel distamycin analogues: facile synthesis of cholesterol conjugates of distamycinlike oligopeptides. Tetrahedron Lett., 2001, 42, 3499-3502;
36. Bhattacharya, S. and Thomas, M., Facile synthesis of novel fluorescent distamycin analogues. Tetrahedron Lett., 2001, 42, 5525-5528.
37. Holmquist, G., Hoechst 33258 fluorescent staining of Drosophila chromosomes. Chromosoma, 1975, 49, 333-356.
38. Ferguson, L. R. and Denny, W. A., Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogs. Mutat. Res., 1995, 329, 19;
39. Bhattacharya, S. and Chaudhuri, P., Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes. Curr. Med. Chem., 2008, 15, 1762-1777.
40. Harshman, K. D. and Dervan, P. B., Molecular recognition of BDNA by Hoechst 33258. Nucl. Acids Res., 1985, 13, 4825-4835.
41. Spink, N., Brown, D. G., Skelly, J. V. and Neidle, S., Sequencedependent effects in drug-DNA interaction: the crystal structure of Hoechst 33258 bound to the d(CGCAAATTTGCG)2 duplex. Nucleic Acids Res., 1994, 22, 1607-1612.
42. Dervan, P. B., Design of sequence-specific DNA-binding molecules. Science, 1986, 232, 464-471.
43. Bhattacharya, S. and Thomas, M., DNA recognition by the first tail-to-tail linked distamycin-like oligopeptide dimers. Chem. Commun., 2001, 1464-1465;
44. Ghosh, S., Usharani, D., Paul, A., De, S., Jemmis, E. D. and Bhattacharya, S., Design, synthesis, and DNA binding properties of photoisomerizable azobenzene-distamycin conjugates: an experimental and computational study. Bioconjugate Chem., 2008, 19, 2332-2345;
45. Ghosh, S., Usharani, D., De, S., Jemmis, E. D. and Bhattacharya, S., Photophysical and duplex-DNA binding properties of distamycin dimers based on 4,4' and 2,2'-dialkoxyazobenzenes as the core. Chem. Asian J., 2008, 3, 1949-1961.
46. Clairac, R. P. L., Seel, C. J., Geierstanger, B. H., Mrksich, M., Baird, E. F., Dervan, P. B. and Wemmer, D. E., NMR characterization of the aliphatic beta/beta. Pairing for recognition of AT/TA base pairs in the minor groove of DNA. J. Am. Chem. Soc., 1999, 121, 2956-2964.
47. Weyermann, P. and Dervan, P. B., Recognition of ten base pairs of DNA by head-to-head hairpin dimers. J. Am. Chem. Soc., 2002, 124, 6872-6878.
48. Mrksich, M. and Dervan, P. B., Enhanced sequence specific recognition in the minor groove of DNA by covalent peptide dimers: bis(pyridine-2-carboxamidonetropsin)(CH2)3-6. J. Am. Chem. Soc., 1993, 115, 9892-9899.
49. Mrksich, M., Parks, M. E. and Dervan, P. B., Hairpin peptide motif. A new class of oligopeptides for sequence-specific recognition in the minor groove of double-helical DNA. J. Am. Chem. Soc., 1994, 116, 7983-7988.
50. Urbach, A. R., Love, J. J., Ross, S. A. and Dervan, P. B., Structure of a beta-alanine-linked polyamide bound to a full helical turn of purine tract DNA in the 1: 1 motif. J. Mol. Biol., 2002, 320, 55-71.
51. Jain, A. K., Gupta, Sharad, K. and Tandon, V., Evaluation of electronic effect of phenyl ring substituents on the DNA minor groove binding properties of novel bis and terbenzimidazoles: Synthesis and spectroscopic studies of ligand-DNA interaction. Oligonucleotides, 2009, 19, 329-340.
52. Joubert, A., Sun, X.-W., Johansson, E., Bailly, C., Mann, J. and Neidle, S., Sequence-selective targeting of long stretches of the DNA minor groove by a novel dimeric bis-benzimidazole. Biochemistry, 2003, 42, 5984-5992.
53. Chaudhuri, P., Ganguly, B. and Bhattacharya, S., An experimental and computational analysis on the differential role of the positional isomers of symmetric bis-2-(pyridyl)-1H-benzimidazoles as DNA binding agents. J. Org. Chem., 2007, 72, 1912-1923.
54. Tanada, M., Tsujita, S. and Sasaki, S., Design of new bidentate ligands constructed of two Hoechst 33258 units for discrimination of the length of two A3T3 binding motifs. J. Org. Chem., 2006, 71, 125-134;
55. Kelly, J. J., Baird, E. E. and Dervan, P. B., Binding site size limit of the 2: 1 pyrrole-imidazole polyamide- DNA motif. Proc. Natl. Acad. Sci. USA, 1996, 93, 6981-6985.
56. Satz, A. L. and Bruice, T. C., Recognition of nine base pairs in the minor groove of DNA by a tripyrrole peptide-hoechst conjugate. J. Am. Chem. Soc., 2001, 123, 2469-2477.
57. Bourdouxhe, C., Colson, P., Houssier, C., Henichart, J. P., Waring, M. J., Denny, W. A. and Bailly, C., Design of composite drug molecules: mutual effects on binding to DNA of an intercalator, amsacrine, and a minor groove binder, netropsin. Anticancer Drug Des., 1995, 10, 131-154.
58. David-Cordonnier, M. H. et al., Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors. Eur. J. Med. Chem., 2007, 42, 752-771.
59. Neves, C., Byk, G., Scherman, D. and Wils, P., Coupling of a targeting peptide to plasmid DNA by covalent triple helix formation. FEBS Lett., 1999, 453, 41-45.
60. Clarenc, J. P., Degols, G., Leonetti, J. P., Milhaud, P. and Lebleu, B., Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation. Anticancer Drug Des., 1993, 8, 81-94.
61. Hangeland, J. J., Levis, J. T., Lee, Y. C. and Ts'o, P. O., Ligand Specific enhancement of cellular uptake of oligodeoxynucleoside methylphosphonates covalently linked with a neoglycopeptide, YEE(ah-GalNAc)3. Bioconjugate Chem., 1995, 6, 695-701.
62. Antopolsky, M. et al., Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties. Bioconjugate Chem., 1999, 10, 598-606.
63. Sahasrabudhe, P. V. and Gmeiner, W. H., The affinity of an oligodeoxynucleotide-peptide conjugate for an RNA hairpin loop depends on stereochemistry at the DNA-peptide junction. J. Biomol. Struct. Dyn., 1996, 13, 585-591.
64. Wiederholt, K., Rajur, S. and McLaughlin, L., Oligonucleotides tethering Hoechst 33258 Derivatives: effect of the conjugation site on duplex stabilization and fluorescence properties. Bioconjugate Chem., 1997, 8, 119-126.
65. Ghosh, S., Defrancq, E., Lhomme, J. H., Dumy, P. and Bhattacharya, S., Efficient conjugation and characterization of distamycin- based peptides with selected oligonucleotide stretches. Bioconjugate Chem., 2004, 15, 520-529.
66. Gianolio, D. A. and McLaughlin, L. W., Tethered naphthalene diimide intercalators enhance DNA triplex stability. Bioorg. Med. Chem., 2001, 9, 2329-2334.
67. Kazuhiko, N., Yoshida, T. and Saito, I., Photochemistry of benzophenone immobilized in a major groove of DNA: formation of thermally reversible interstrand cross-link. J. Am. Chem. Soc., 2002, 124, 2118-2119.
68. Sinyakov, A. N., Lokhov, S. G., Kutyavin, I. V., Gamper, H. B. and Meyer, R. B., Exceptional and selective stabilization of A-T rich DNA-DNA duplexes by N-methylpyrrole carboxamide peptides conjugated to oligodeoxynucleotides. J. Am. Chem. Soc., 1995, 117, 4995-4996.
69. Vlassov, V. V. et al., Sequence-specific chemical modification of double-stranded DNA with alkylating oligodeoxyribonucleotide derivatives. Gene, 1988, 72, 313-322.
70. Singh, Y., Edupuganti, O. P., Villien, M., Defrancq, E. and Dumy, P., The oxime bond formation as a useful tool for the preparation of oligonucleotide conjugates. C.R. Chim., 2005, 8, 789-796;
71. Singh, Y., Gunnar, T., Dolphin, G. T., Razkin, J. and Dumy, P., Synthetic peptide templates for molecular recognition: recent advances and applications. ChemBioChem., 2006, 7, 1298-1314.
72. Pei, D., Corey, D. R. and Schultz, P. G., Site-specific cleavage of duplex DNA by a semisynthetic nuclease via triple-helix formation. Proc. Natl. Acad. Sci. USA, 1990, 87, 9858-9862.
73. Povsic, T. J. and Dervan, P. B., Sequence-specific alkylation of double-helical DNA by oligonucleotide-directed triple-helix formation. J. Am. Chem. Soc., 1990, 112, 9428-9430.
74. Tong, G., Lawlor, J. M., Tregear, G. W. and Haralamibids, J., Oligonucleotide-polyamide hybrid molecules containing multiple pyrene residues exhibit significant excimer fluorescence. J. Am. Chem. Soc., 1995, 117, 12151-12158.
75. Franqois, J. C., Saison-Behmoaras, T., Barbier, C., Chassignol, M., Thuong, N. T. and Helene, C., Sequence-specific recognition and cleavage of duplex DNA via triple-helix formation by oligonucleotides covalently linked to a phenanthroline-copper chelate. Proc. Natl. Acad. Sci. USA, 1989, 86, 9702-9706.
76. Sigman, D. S., Nuclease activity of 1,10-phenanthroline-copper ion. Acc. Chem. Res., 1986, 19, 180-186.
77. Rosenberg, B., VanCamp, L. and Krigas, T., Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature, 1965, 205, 698-699.
78. Ge, R. and Sun, H., Bioinorganic chemistry of bismuth and antimony: target sites of metallodrugs. Acc. Chem. Res., 2007, 40, 267-274.
79. Wang, D. and Lippard, S. J., Cellular processing of platinum anticancer drugs. Nature Rev. Drug Discov., 2005, 4, 307-320.
80. Umezawa, H., Structure and action of bleomycin. Prog. Biochem. Pharmacol., 1976, 11, 18-27.
81. Wong, E. and Giandomenico, C. M., Current status of platinumbased antitumour drugs. Chem. Rev., 1999, 99, 2451-2466
82. Decatris, M. P., Sundar, S. and O'Byrne, K. J., Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat. Rev., 2004, 30, 53-81.
83. Bonnett, R., Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev., 1995, 24, 19-33.
84. Stubbe, J. and Kozarich, J. W., Mechanisms of bleomycininduced DNA degradation. Chem. Rev., 1987, 87, 1107-1136
85. Hutchinson, F., Chemical changes induced in DNA by ionizing radiation. Prog. Nucleic Acid Res., Mol. Biol., 1985, 32, 115-154
86. Murphy, J. A., Reactions of oxyl radicals with DNA. Free Radic. Biol. Med., 1995, 18, 1033-1077.
87. Burrows, C. J. and Muller, J. G., Oxidative nucleobase modifications leading to strand Scission. Chem. Rev., 1998, 98, 1109-1151.
88. Pratviel, G., Bernadou, J. and Meunier, B., Carbon-hydrogenbonds of DNA sugar units as targets for chemical nucleases and drugs. Angew. Chem., Int. Ed. Engl., 1995, 34, 746-769.
89. Schärer, O. D., Chemistry and biology of DNA repair. Angew. Chem., Int. Ed. Engl., 2003, 42, 2946-2974.
90. Benites, P. J. et al., Metal-ligand charge-transfer-promoted photoelectronic Bergman cyclization of copper metalloenediynes: photochemical DNA cleavage via C-4' H-atom abstraction. J. Am. Chem. Soc., 2003, 125, 6434.
91. Ali, H. and van Lier, J. E., Metal complexes as photo- and radiosensitizers. Chem. Rev., 1999, 99, 2379-2450.
92. Chow, C. S. and Barton, J. K., Transition metal complexes as probes of nucleic acids. Methods Enzymol., 1992, 212, 219-242.
93. Sitlani, A., Long, E. C., Pyle, A. M. and Barton, J. K., DNA photocleavage by phenanthrenequinone diimine complexes of rhodium(III): shape-selective recognition and reaction. J. Am. Chem. Soc., 1992, 114, 2303-2312.
94. Angeles-Boza, A. M., Chifotides, H. T., Aguirre, J. D., Chouai, A., Fu, P. K.-L., Dunbar, K. R. and Turro, C., Dirhodium( II,II) Complexes: molecular characteristics that affect in vitro activity. J. Med. Chem., 2006, 49, 6841-6847;
95. Angeles- Boza, A. M., Bradley, P. M., Fu, P. K.-L., Wicke, S. E., Bacsa, J., Dunbar, K. R. and Turro, C., DNA binding and photocleavage in vitro by new dirhodium(II) dppz complexes: correlation to cytotoxicity and photocytotoxicity. Inorg. Chem., 2004, 43, 8510-8519.
96. Hergueta-Bravo, A., Jimnez-Hernndez, M. E., Montero, F., Oliveros, E. and Orellana, G., Singlet oxygen-mediated DNA photocleavage with Ru(II) polypyridyl complexes. J. Phys. Chem. B, 2002, 106, 4010-4017.
97. Erkilla, K. E., Odom, D. T. and Barton, J. K., Recognition and reaction of metallointercalators with DNA. Chem. Rev., 1999, 99, 2777-2795.
98. Zhou, Q.-X., Lei, W.-H., Li, C., Hou, Y.-J., Wang, X.-S. and Zhang, B.-W., DNA photocleavage in anaerobic conditions by a Ru(II) polypyridyl complex with long wavelength MLCT absorption. New J. Chem., 2010, 34, 137-140.
99. Rose, M. J., Fry, N. L., Marlow, R., Hinck, L. and Mascharak, P. K., Metal complexes as photochemical nitric oxide precursors: potential applications in the treatment of tumours. J. Am. Chem. Soc., 2008, 130, 8834.
100. Rose, M. J., Fry, N. L., Marlow, R., Hinck, L. and Mascharak, P. K., Sensitization of ruthenium nitrosyls to visible light via direct coordination of the dye resorufin: trackable NO donors for light-triggered NO delivery to cellular targets. J. Am. Chem. Soc., 2008, 130, 8834-8846;
101. Ostrowski, A. D. and Ford, P. C., Metal complexes as photochemical nitric oxide precursors: Potential applications in the treatment of tumours. Dalton Trans., 2009, 10660-10669.
102. Mackay, F. S. et al., A potent cytotoxic photoactivated platinum complex. Proc. Natl. Acad. Sci. USA, 2007, 104, 20743-20748.
103. Eppley, H. J., Lato, S. M., Ellington, A. D. and Zaleski, J. M., Chem. Commun., 1999, 2405.
104. Reddy, P. A. N., Santra, B. K., Nethaji, M. and Chakravarty, A. R., Metal-assisted light-induced DNA cleavage activity of 2-(methylthio)phenylsalicylaldimine Schiff base copper(II) complexes having planar heterocyclic bases. J. Inorg. Biochem., 2004, 98, 377-386.
105. Patra, A. K., Dhar, S., Nethaji, M. and Chakravarty, A. R., Visible light-induced nuclease activity of a ternary mono-phenanthroline copper(II) complex containing L-methionine as a photosensitizer. Chem. Commun., 2003, 1562-1563.
106. Dhar, S., Senapati, D., Das, P. K., Chattaopadhyay, P., Nethaji, M. and Chakravarty, A. R., Ternary copper complexes for photocleavage of DNA by red light: direct evidence for sulfur-tocopper charge transfer and d-d band involvement. J. Am. Chem. Soc., 2003, 125, 12118-12124.
107. Chang, C. H. and Meares, C. F., Light-induced nicking of deoxyribonucleic acid by cobalt(III) bleomycins. Biochemistry, 1982, 21, 6332-6334;
108. Saito, I., Morii, T., Sugiyama, H., Matsuura, T., Meares, C. F. and Hecht, S. M., Photoinduced DNA strand scission by cobalt bleomycin green complex. J. Am. Chem. Soc., 1989, 111, 2307-2308.
109. Bhattacharya, S. and Mandal, S. S., Ambient oxygen activating water soluble cobalt-salen complex for DNA cleavage. J. Chem. Soc. Chem. Commun., 1995, 2489-2490.
110. Mandal, S. S., Kumar, N. V., Varshney, U. and Bhattacharya, S., Metal-ion-dependent oxidative DNA cleavage by transition metal complexes of a new water-soluble salen derivative. J. Inorg. Biochem., 1996, 63, 265-272;
111. Mandal, S. S., Kumar, N. V., Varshney, U. and Bhattacharya, S., Role of the central metal ion and ligand charge in the DNA binding and modification by metallosalen complexes. Bioconjugate Chem., 1997, 8, 798-812.
112. Barton, J. K. and Raphael, A. L., Photoactivated stereospecific cleavage of double-helical DNA by cobalt(III) complexes. J. Am. Chem. Soc., 1984, 106, 2466-2468;
113. Barton, J. K. and Paranawithana, S. R., Restriction endonuclease EcoRI alters the enantiomeric preference of chiral conformational change metallointercalators for DNA: An illustration of a protein-induced DNA. Biochemistry, 1986, 25, 2205-2211.
114. Tanaka, M., Ohkubo, K. and Fukuzumi, S., DNA cleavage induced by photoirradiation of coenzyme B12 and organocobaloximes without dioxygen. J. Photochem. Photobiol. A., 2008, 197, 94-100;
115. Arounaguiri, S. and Maiya, B. G., Dipyridophenazine complexes of cobalt(III) and nickel(II): DNA-binding and photocleavage studies. Inorg. Chem., 1996, 35, 4267-4270.
116. Bhattacharya, S. and Mandal, S. S., DNA cleavage by intercalatable cobalt-bispicolylamine complexes activated by visible light. Chem. Commun., 1996, 1515-1516.
117. Maurer, T. D., Kraft, B. J., Lato, S. M., Ellington, A. D. and Zaleski, J. M., Photoactivated DNA cleavage via charge transfer promoted N2 release from tris[3-hydroxy-1,2,3-benzotriazine- 4(3H)-one]iron(III). Chem. Commun., 2000, 69-70.
118. Mohler, D. L., Coonce, J. G. and Predecki, D., Photoinduced DNA cleavage by benzenediradical equivalents: 1,3- and 1,4- bis(dicarbonylcyclopentadienyl-iron) benzene. Bioorg. Med. Chem. Lett., 2003, 13, 1377-1379.
119. Ramakrishnan, S., Suresh, E., Riyasdeen, A., Akbarsha, A. M. and Palaniandavar, M., DNA binding, prominent DNA cleavage and efficient anticancer activities of tris(diimine)iron(II) complexes. Dalton Trans., 2011, 40, 3524-3536.
120. Ansari, K. I., Kasiri, S., Grant, J. D. and. Mandal, S. S., Apoptosis and anti-tumour activities of manganese(III)-salen and salphen complexes. Dalton Trans., 2009, 8525-8531.
121. Ansari, K. I., Grant, J. D., Kasiri, S., Woldemariam, G., Shrestha, B. and Mandal, S. S., Manganese(III)-salens induce tumour selective apoptosis in human cells. J. Inorg. Biochem., 2009, 103, 818-826.
122. Kim, O. K., Barrett, J. F. and Ohemeng, K., Advances in DNA gyrase inhibitors. Expert Opin. Invest. Drugs, 2001, 10, 199-212
123. Pourquier, P. and Pommier, Y., Topoisomerase I-mediated DNA damage. Adv. Cancer Res., 2001, 80189-80216.
124. Maxwell, A. and Gellert, M., Mechanistic aspects of DNA topoisomerases. Adv. Protein Chem., 1986, 38, 69-107.
125. Crick, F. H. C., Wang, J. C. and Brucer, W. R., Is DNA really a double helix? J. Mol. Biol., 1979, 129, 449-461.
126. Wang, J. C., DNA topoisomerases. Annu. Rev. Biochem., 1996, 65, 635-692.
127. Pommier, Y., Pourquier, P., Fan, Y. and Strumberg, D., Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta, 1998, 1400, 83-105.
128. Chatterji, M. and Nagaraja, V., GyrI: a counter-defensive strategy against proteinaceous inhibitors of DNA gyrase. EMBO Rep., 2002, 261-267;
129. Manjunatha, U. H., Dalal, M., Chatterji, M., Radha, D. R., Visweswariah, S. and Nagraja, V., Functional characterisation of mycobacterial gyrase: an efficient decatenase. Nucleic Acids Res., 2002, 30, 2144-2153.
130. Bakshi, R. P., Galande, S. and Muniyappa, K., Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase. Crit. Rev. Biochem. Mol. Biol., 2001, 36, 1-37.
131. Yang, Z. and Champoux, J. J., The role of histidine 632 in catalysis by human topoisomerase I. J. Biol. Chem., 2001, 276, 677-685.
132. Froelich-Ammon, S. J. and Osheroff, N., Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem., 1995, 270, 21429-21432;
133. Chaudhuri, P., Majumder, H. K. and Bhattacharya, S., Synthesis, DNA binding and leishmania topoisomerase inhibition activities of a novel series of anthra[1,2-d]imidazole-6,11-dione derivatives. J. Med. Chem., 2007, 50, 2536-2540.
134. Liu, L. F., Duann, P., Lin, C. T., D'Arpa, P. and Wu, J., Mechanism of action of camptothecin. Ann. N. Y. Acad. Sci., 1996, 13, 803-844.
135. Hsiang, Y. H., Hertzberg, R., Hecht, S. and Liu. L. F., Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 1985, 260, 14873-14878.
136. Binaschi, M., Zunino, F. and Capranico, G., Mechanism of action of DNA topoisomerase inhibitors. Stem Cells, 1995, 13, 369-379.
137. Bailly, C., Topoisomerase I poisons and suppressors as anticancer drugs. Curr. Med. Chem., 2000, 7, 39-58.
138. Beerman, T. A., McHugh, M. M., Sigmund, R., Lown, J. W., Rao, K. E. and Bathini, Y., Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities. Biochim. Biophys. Acta, 1992, 1131, 53-61.
139. Chen, A. Y., Yu, C., Gatto, B. and Liu, L. F., DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc. Natl. Acad. Sci. USA, 1993, 90, 8131-8135.
140. Jean-Moreno, V., Rojas, R., Goyeneche, D., Coombs, G. H. and Walker, J., Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp. Parasitol., 2006, 112, 21-30;
141. Ray, S., Hazra, B., Mittra, B. M., Das, A. and Majumder, H. K., Diospyrin, a bisnaphthoquinone; a novel inhibitor of type I DNA Topoisomerase of Leishmania donovani. Mol. Pharmacol., 1998, 54, 994-999.
142. Das, A., Dasgupta, A., Sengupta, T. and Majumder, H. K., Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets. Trends Parasitol., 2004, 20, 381-387.
143. Chaudhuri, P., Majumder, H. K. and Bhattacharya, S., Synthesis, DNA binding, and Leishmania topoisomerase inhibition activities of a novel series of anthra[1,2-d]imidazole-6,11-dione derivatives. J. Med. Chem., 2007, 50, 2536-2540.
144. Kim, N. W., Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266, 2011-2015.
145. Herbert, B., Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. USA, 1999, 96, 14276-14281.
146. Hahn, W. C. et al., Inhibition of telomerase limits the growth of human cancer cells. Nature Med., 1999, 10, 1164-1170.
147. Gilbert, D. E. and Feigon, J., Multistranded DNA structures. Curr. Opin. Struct. Biol., 1999, 9, 305-314;
148. Kerwin, S. M., G-quadruplex DNA as a target for drug design. Curr. Pharm. Des., 2000, 6, 441-471.
149. Alberti, P., Lacroix, L., Guittat, L., Helene, C. and Mergny, J. L., Nucleic acids as targets for antitelomerase agents. Mini Rev. Med. Chem., 2003, 3, 23-36.
150. Gellert, M., Lipsett, M. N. and Davies, D. R., Helix formation by guanylic acid. Proc. Natl. Acad. Sci. USA, 1962, 48, 2013-2018.
151. Hud, N. V. and Plavec, J., Royal Society of Chemistry Publishing, Cambridge, 2006, p. 100.
152. Phillips, K., Dauter, Z., Murchie, A. I. H., Lilley, D. M. J. and Luisi, B., The crystal structure of a parallel-stranded guanine tetraplex at 0.95 ANG resolution. J. Mol. Biol., 1997, 273, 171-182.
153. Neidle, S. and Parkinson, G., Telomere maintenance as a target for anticancer drug discovery. Nature Rev. Drug Discov., 2002, 1, 383-393.
154. Aisner, D. L., Wright, W. E. and Shay, J. W., Telomerase regulation: not just flipping the switch. Curr. Opin. Genet. Dev., 2002, 12, 80-85.
155. Shay, J. W. and Wright, W. E., Hayflick, his limit, and cellular ageing. Nature Rev. Mol. Cell. Biol., 2000, 1, 72-76.
156. Bodnar, A. G. et al., Extension of life-span by introduction of telomerase into normal human cells. Science, 1998, 279, 349-352.
157. Hahn, W. C. and Weinberg, R. A., N. Engl. J. Med., 2002, 347, 1593.
158. Harley, C. B., Telomerase therapeutics for degenerative diseases. Curr. Mol. Med., 2005, 5, 205-211.
159. Neumann, A. A. and Reddel, R. R., Opinion: Telomere maintenance and cancer -look, no telomerase. Nature Rev. Cancer, 2002, 2, 879-884.
160. Blackburn, E. H., Telomere states and cell fates. Nature, 2000, 408, 53-56.
161. de Lange, T., Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev., 2005, 19, 2100-2110.
162. Moyzis, R. K. et al., A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA, 1988, 85, 6622-6626.
163. Wright, W. E., Tesmer, V. M., Huffman, K. E., Levene, S. D. and Shay, J. W., Normal human chromosomes have long, G-rich telomeric overhangs at one end. Genes Dev., 1997, 11, 2801-2809.
164. Court, R., Chapman, L., Fairall, L. and Rhodes, D., How the human telomeric proteins TRF1 and TRF2 recognize telomeric DNA: a view from high-resolution crystal structures. EMBO Rep., 2005, 6, 39-45.
165. Xin, H. et al., TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature, 2007, 445, 559-562.
166. Hurley, L. H. et al., G-quadruplexes as targets for drug design. Pharmacol. Ther., 2000, 85, 141-158.
167. Punchihewa, C., Yang, D. and Hiyama, K., Humana Press, Totowa, NJ, USA, 2009, p. 251.
168. Harley, C. B., Futcher, A. B. and Greider, C. W., Nature, 1990, 345, 458.
169. Greider, C. W. and Blackburn, E. H., Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 1985, 43, 405-413.
170. Kim, N. W., Piatyszek, M. A. and Prowse, K. R., Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266, 2011-2015.
171. Hanahan, D. and Weinberg, R. A., The hallmarks of cancer. Cell, 2000, 100, 57-70.
172. Zahler, A. M., Williamson, J. R., Cech, T. R. and Prescott, D. M., Inhibition of telomerase by G-quartet DNA structures. Nature, 1991, 350, 718-720.
173. Griffith, J., Bianchi, A. and de Lange, T., RF1 promotes parallel pairing of telomeric tracts in vitro. J. Mol. Biol., 1998, 278, 79-88.
174. Sundquist, W. I. and Klug, A., Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops. Nature, 1989, 342, 825-829.
175. Shukla, A. K. and Roy, K. B., Rec. Biol. Chem., 2006, 387, 251.
176. Parkinson, G. N., Lee, M. P. and Neidle, S., Telomere maintenance as a target for anticancer drug discovery. Nature, 2002, 417, 876-880.
177. Ambrus, A., Chen, D., Dai, J., Bialis, T., Jones, R. A. and Yang, D., Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Res., 2006, 34, 2723-2735.
178. Dai, J. X., Carver, M., Punchihewa, C., Jones, R. A. and Yang, D., Structure of the hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: Insights into structure polymorphism of the human telomeric sequence. Nucleic Acids Res., 2007, 35, 4927-4940;
179. Luu, N. K., Phan, A. T., Kuryavyi, V., Lacroix, L. and Patel, D. J., Structure of the human telomere in K+ solution: an intramolecular (3 + 1) G-quadruplex scaffold. J. Am. Chem. Soc., 2006, 128, 9963-9970.
180. Dai, J. X., Punchihewa, C., Ambrus, A., Chen, D., Jones, R. A. and Yang, D. Z., Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation. Nucleic Acids Res., 2007, 35, 2440-2450.
181. Vorlickova, M., Chladkova, J., Kejnovska, I., Fialova, M. and Kypr, J., Guanine tetraplex topology of human telomere DNA is governed by the number of (TTAGGG) repeats. Nucleic Acids Res., 2005, 33, 5851-5860.
182. Martadinata, H. and Phan, A. T., Structure of propeller-type parallel-stranded RNA G-quadruplexes, formed by human telomeric RNA sequences in K+ solution. J. Am. Chem. Soc., 2009, 131, 2570-2578.
183. Pomerantz, A. K., Moerner, W. E. and Kool, E. T., Visualization of long human telomere mimics by single-molecule fluorescence imaging. J. Phys. Chem. B, 2008, 112, 13184-13187;
184. Bates, P., Jean-Louis Mergny, J. L. and Yang, D., Quarters in G-major. EMBO Reports, 2007, 8, 1003-1010.
185. Randall, A. and Griffith, J. D., Structure of long telomeric RNA transcripts: the G-rich RNA forms a compact repeating structure containing G-quartets. J. Biol. Chem., 2009, 284, 13980-13986.
186. Petraccone, L., Trent, J. O. and Chaires, J. B., The tail of the telomere. J. Am. Chem. Soc., 2008, 130, 16530-16532.
187. Rezler, E. M., Bearss, D. J. and Hurley, L. H., Telomere inhibition and telomere disruption as processes for drug targeting. Annu. Rev. Pharmacol. Toxicol., 2003, 43, 359-379.
188. Cuesta, J., Read, M. A. and Neidle, S., The design of Gquadruplex ligands as telomerase inhibitors. Mini Rev. Med. Chem., 2003, 3, 11-21.
189. Haider, S. M., Parkinson, G. N. and Neidle, S., Structure of a G-quadruplex-ligand complex. J. Mol. Biol., 2003, 326, 117-125.
190. Parkinson, G. N., Ghosh, R. and Neidle, S., Structural basis for binding of porphyrin to human telomeres. Biochemistry, 2007, 46, 2390-2397.
191. Campbell, N. H., Parkinson, G. N., Reszka, A. P. and Neidle, S., Structural basis of DNA quadruplex recognition by an acridine drug. J. Am. Chem. Soc., 2008, 130, 6722-6724.
192. Parkinson, G. N., Cuenca, F. and Neidle, S., Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. J. Mol. Biol., 2008, 381, 1145-1156.
193. Campbell, N. H., Patel, M., Tofa, A. B., Ghosh, R., Parkinson, G. N. and Neidle, S., Selectivity in ligand recognition of G-quadruplex loops. Biochemistry, 2009, 48, 1675-1680.
194. Searle, M. S. and Balkwill, G. D., Nucleic Acids (eds Neidle, S. and Balasubramanian, S.), Royal Society of Chemistry, Cambridge, 2006, pp. 131-153.
195. Phan, A. T., Kuryavyi, V., Gaw, H. Y. and Patel, D. J., Smallmolecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter. Nature Chem. Biol., 2005, 1, 167-173.
196. Dixon, I. M., Lopez, F., Tejera, A. M., Estève, J. P., Blasco, M. A., Pratviel, G. and Meunier, B. A., G-quadruplex ligand with 10000-fold selectivity over duplex DNA. J. Am. Chem. Soc., 2007, 129, 1502-1503;
197. Jain, A. K., Reddy, V. V., Paul, A., Muniyappa, K. and Bhattacharya, S., Synthesis and evaluation of a novel class of G-quadruplex-stabilizing small molecules based on the 1,3-phenylene-bis(piperazinyl benzimidazole) system. Biochemistry, 2009, 48, 10693-10704.
198. Kettani, A. et al., A dimeric DNA interface stabilized by stacked A(GGGG)A hexads and coordinated monovalent cations. J. Mol. Biol., 2000, 297, 627-644.
199. Datta, B., Schmitt, C. and Armitage, B. A., Synthesis and characterization of thermoreversible biopolymer microgels based on hydrogen-bonded nucleobase pairing. J. Am. Chem. Soc., 2003, 125, 4111-4118.
200. Xu, Y., Yamazaki, S., Osuga, H. and Sugiyama, H., The recognition of higher-order G-quadruplex by chiral cyclic-helicene molecules. Nucl. Acids Symp. Ser., 2006, 50, 183-184.
201. Chang, C. C. et al., Detection of quadruplex DNA structures in human telomeres by a fluorescent carbazole derivative. Anal. Chem., 2004, 76, 4490-4494.
202. Yang, P., De Cian, A., Teulade-Fichou, M. P., Mergny, J. L. and Monchaud, D., Engineering bisquinolinium/thiazole orange conjugates for fluorescent sensing of G-quadruplex DNA. Angew. Chem., Int. Ed. Engl., 2009, 48, 2188-2191.
203. Bhattacharya, S., Chaudhuri, P., Jain, A. K. and Paul, A., Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition. Bioconjugate Chem., 2010, 21, 148-159.
204. Mergny, J. L. et al., Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc. Natl. Acad. Sci. USA, 2001, 98, 3062-3067.
205. Read, M. et al., Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc. Natl. Acad. Sci. USA, 2001, 98, 4844-4849.
206. Han, F. X. G., Wheelhouse, R. T. and Hurley, L. H., Interactions of TMPyP4 and TMPyP2 with quadruplex DNA. Structural basis for the differential effects on telomerase inhibition. J. Am. Chem. Soc., 1999, 121, 3561-3570.
207. Neidle, S., Harrison, R. J., Reszka, A. P. and Read, M. A., Structure-activity relationships among guanine-quadruplex telomerase inhibitors. Pharmacol. Ther., 2000, 85, 133-139.
208. Fedoroff, O. Y., Salazar, M., Han, H. Y., Chemeris, V. V., Kerwin, S. M. and Hurley, L. H., NMR-based model of a telomeraseinhibiting compound bound to G-quadruplex DNA. Biochemistry, 1998, 37, 12367-12374.
209. Gowan, S. M., Heald, R. A., Stevens, M. F. G. and Kelland, L. R., Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Mol. Pharmacol., 2001, 60, 981-988.
210. Heald, R. A. et al., Antitumour polycyclic acridines. Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. J. Med. Chem., 2002, 45, 590-597.
211. Teulade-Fichuo, M.-P. et al., Selective recognition of G-quadruplex telomeric DNA by a bis(quinacridine) macrocycle. J. Am. Chem. Soc., 2003, 125, 4732-4740.
212. Riou, J. F. et al., Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res., 2001, 29, 10871-10896.
213. Murphy, P. M., Phillips, V. A., Jennings, S. A., Garbett, N. C., Chaires, J. B., Jenkins, T. C. and Wheelhouse, R. T., Biarylpyrimidines: a new class of ligand for high-order DNA recognition. Chem. Commun., 2003, 1160-1161.
214. Maraval, A., Franco, S., Vialas, C., Pratviel, G., Blasco, M. A. and Meunier, B., Alkylation of manganese(II) tetraphenylporphyrin by a synthetic antimalarial trioxane. Org. Biomol. Chem., 2003, 1, 921-927.
215. Guyen, B., Schultes, C. M., Hazel, P., Mann, J. and Neidle, S., Synthesis and evaluation of analogs of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilizing ligands and potential inhibitors of the enzyme telomerase. Org. Biomol. Chem., 2004, 2, 981-988.
216. Schouten, J. A., Ladame, S., Mason, S. J., Cooper, M. A. and Balasubramanian, S., G-quadruplex-specific peptide-hemicyanine ligands by partial combinatorial selection. J. Am. Chem. Soc., 2003, 125, 5594-5595.
217. Isalan, M., Patel, S. D., Balasubramanian, S. and Choo, Y., Selection of zinc fingers that bind single-stranded telomeric DNA in the G-quadruplex conformation. Biochemistry, 2001, 40, 830-836.
218. Schaffitzel, C., Berger, I., Postberg, J., Hanes, J., Lipps, H. J. and Pluckthun, A., In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc. Natl. Acad. Sci. USA, 2001, 98, 8572-8577.
219. Shin-ya, K. et al., Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J. Am. Chem. Soc., 2001, 123, 1262-1263.
220. Kim, M.-Y., Vankayalapati, H., Shin-ya, K., Wierzba, K. and Hurley, L. H., Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J. Am. Chem. Soc., 2002, 124, 2098-2099.